Skip to main content
Premium Trial:

Request an Annual Quote

Laurence Reid

Alnylam Pharmaceuticals said today that Chief Business Officer Laurence Reid will resign from the company at the end of 2014. Reid will be joining venture capital firm Third Rock Ventures as an entrepreneur-in-residence. He is expected to become CEO of a Third Rock Ventures-funded company in the future. Reid joined Alnylam in 2010.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.